Correction to: Vitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: A novel approach with preclinical evidence (ACS Chemical Neuroscience (2017) 6:6 (1390-1396) DOI: 10.1021/acschemneuro.7b00041);Vitamin-Derived Nanolipoidal Carriers for Brain Delivery of Dimethyl Fumarate: A Novel Approach with Preclinical Evidence

ACS Chemical Neuroscience

Volumn 8, Issue 6, 2017, Pages 1390-1396

  Kumar, Pramod ^a   Sharma, Gajanand ^b   Kumar, Rajendra ^c   Malik, Ruchi ^a   Singh, Bhupinder ^b,c   Katare, O P ^b   Raza, Kaisar ^a  

^a CENTRAL UNIVERSITY OF RAJASTHAN   (India)

^b PANJAB UNIVERSITY   (India)

^c PANJAB UNIVERSITY   (India)

Author keywords

drug delivery; multiple sclerosis; once a day delivery; SH SY5Y cells; SLNs; Vitamin A acetate; Vitamin D3

Indexed keywords

CHOLECALCIFEROL SOLID LIPID NANOPARTICLE; COLECALCIFEROL; FUMARIC ACID DIMETHYL ESTER; RETINOL ACETATE; RETINOL ACETATE SOLID LIPID NANOPARTICLE; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER; IMMUNOSUPPRESSIVE AGENT; LIPID; NANOPARTICLE; RETINOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CACO-2 CELL LINE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA PERMEABILITY; LIVER METABOLISM; MALE; MAXIMUM PLASMA CONCENTRATION; NANOPHARMACEUTICS; NERVE CELL; NEUROBLASTOMA CELL LINE; NONHUMAN; PARTICLE SIZE; PRECLINICAL STUDY; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUME OF DISTRIBUTION; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; BRAIN; CACO-2 CELLS; CHOLECALCIFEROL; DIMETHYL FUMARATE; DRUG CARRIERS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPIDS; NANOPARTICLES; RATS; TISSUE DISTRIBUTION; VITAMIN A;

EID: 85021116288     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.7b00324     Document Type: Erratum

References (34)

1. Das, S. and Chaudhury, A. (2011) Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery AAPS PharmSciTech 12, 62-76 10.1208/s12249-010-9563-0
2. Banks, W. A. (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery Nat. Rev. Drug Discovery 15, 275-292 10.1038/nrd.2015.21
3. Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., and Begley, D. J. (2010) Structure and function of the blood-brain barrier Neurobiol. Dis. 37, 13-25 10.1016/j.nbd.2009.07.030
4. Upadhyay, R. K. (2014) Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier BioMed Res. Int. 2014, 869269 10.1155/2014/869269
5. Scherrmann, J. M. (2002) Drug delivery to brain via the blood-brain barrier Vasc. Pharmacol. 38, 349-354 10.1016/S1537-1891(02)00202-1
6. Pillai, G. (2014) Nanomedicines for Cancer Therapy: An Update of FDA Approved and Those under Various Stages of Development SOJPPS 1, 13 10.15226/2374-6866/1/2/00109
7. Garcia-Garcia, E., Andrieux, K., Gil, S., and Couvreur, P. (2005) Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int. J. Pharm. 298, 274-292 10.1016/j.ijpharm.2005.03.031
8. Kumar, P., Raza, K., Kaushik, L., Malik, R., Arora, S., and Katare, O. P. (2016) Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review Curr. Pharm. Des. 22, 5127-5143 10.2174/1381612822666160524144926
9. Tseng, Y.-Y., Kao, Y.-C., Liao, J.-Y., Chen, W.-A., and Liu, S.-J. (2013) Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies ACS Chem. Neurosci. 4, 1314-1321 10.1021/cn400108q
10. Kundu, P., Das, M., Tripathy, K., and Sahoo, S. K. (2016) Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease ACS Chem. Neurosci. 7, 1658-1670 10.1021/acschemneuro.6b00207
11. Blasi, P., Giovagnoli, S., Schoubben, A., Ricci, M., and Rossi, C. (2007) Solid lipid nanoparticles for targeted brain drug delivery Adv. Drug Delivery Rev. 59, 454-477 10.1016/j.addr.2007.04.011
12. Kaur, I. P., Bhandari, R., Bhandari, S., and Kakkar, V. (2008) Potential of solid lipid nanoparticles in brain targeting J. Controlled Release 127, 97-109 10.1016/j.jconrel.2007.12.018
13. Torkildsen, Ø., Løken-Amsrud, K. I., Wergeland, S., Myhr, K.-M., and Holmøy, T. (2013) Fat-soluble vitamins as disease modulators in multiple sclerosis Acta Neurol. Scand. Suppl. 127, 16-23 10.1111/ane.12045
14. DeLuca, G. C., Kimball, S. M., Kolasinski, J., Ramagopalan, S. V., and Ebers, G. C. (2013) Review: the role of vitamin D in nervous system health and disease Neuropathol. Appl. Neurobiol. 39, 458-484 10.1111/nan.12020
15. Bitarafan, S., Saboor-Yaraghi, A., Sahraian, M.-A., Nafissi, S., Togha, M., Beladi Moghadam, N., Roostaei, T., Siassi, F., Eshraghian, M.-R., Ghanaati, H., Jafarirad, S., Rafiei, B., and Harirchian, M.-H. (2015) Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis Arch. Iran. Med. 18, 435-440
16. Anonymous (2010) Vitamin D: hope on the horizon for MS prevention? Lancet Neurol. 9, 555 10.1016/S1474-4422(10)70121-6
17. Mrowietz, U., Altmeyer, P., Bieber, T., Röcken, M., Schopf, R. E., and Sterry, W. (2007) Treatment of psoriasis with fumaric acid esters (Fumaderm) J. Dtsch. Dermatol. Ges. 5, 716-717 10.1111/j.1610-0387.2007.06346.x
18. Linker, R. A. and Gold, R. (2013) Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects Curr. Neurol. Neurosci. Rep. 13, 394 10.1007/s11910-013-0394-8
19. Papadopoulou, A., D'Souza, M., Kappos, L., and Yaldizli, Ö. (2010) Dimethyl fumarate for multiple sclerosis Expert Opin. Invest. Drugs 19, 1603-1612 10.1517/13543784.2010.534778
20. Bomprezzi, R. (2015) Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview Ther. Adv. Neurol. Disord. 8, 20-30 10.1177/1756285614564152
21. Litjens, N. H. R., Burggraaf, J., van Strijen, E., van Gulpen, C., Mattie, H., Schoemaker, R. C., van Dissel, J. T., Thio, H. B., and Nibbering, P. H. (2004) Pharmacokinetics of oral fumarates in healthy subjects Br. J. Clin. Pharmacol. 58, 429-432 10.1111/j.1365-2125.2004.02145.x
22. Kumar, P., Sharma, G., Kumar, R., Malik, R., Singh, B., Katare, O. P., and Raza, K. (2017) Enhanced brain delivery of dimethyl fumarate employing tocopherol acetate-based nanolipidic carriers: Evidences from pharmacokinetic, biodistribution and cellular uptake studies ACS Chem. Neurosci. 10.1021/acschemneuro.6b00428
23. Kulkarni, S. A. and Feng, S.-S. (2013) Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery Pharm. Res. 30, 2512-2522 10.1007/s11095-012-0958-3
24. Dash, S., Murthy, P. N., Nath, L., and Chowdhury, P. (2010) Kinetic modeling on drug release from controlled drug delivery systems Acta Polym. Pharm. 67, 217-223
25. Madhwi Kumar, R., Kumar, P., Singh, B., Sharma, G., Katare, O. P., and Raza, K. (2017) In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles Int. J. Pharm. 519, 138-144 10.1016/j.ijpharm.2017.01.021
26. Angelis, I. D. and Turco, L. (2011) Caco-2 cells as a model for intestinal absorption Curr. Protoc. Toxicol. 20.6 10.1002/0471140856.tx2006s47
27. Kumar, P., Kumar, R., Singh, B., Malik, R., Sharma, G., Chitkara, D., Katare, O. P., and Raza, K. (2016) Biocompatible phospholipid-based mixed micelles for tamoxifen delivery: Promising evidences from in -vitro anticancer activity and dermatokinetic studies AAPS PharmSciTech 10.1208/s12249-016-0681-1
28. Van Breemen, R. B. and Li, Y. (2005) Caco-2 cell permeability assays to measure drug absorption Expert Opin. Drug Metab. Toxicol. 1, 175-185 10.1517/17425255.1.2.175
29. Beg, S., Raza, K., Kumar, R., Chadha, R., Katare, O. P., and Singh, B. (2016) Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium RSC Adv. 6, 8173-8187 10.1039/C5RA24278A
30. Raza, K., Kumar, D., Kiran, C., Kumar, M., Guru, S. K., Kumar, P., Arora, S., Sharma, G., Bhushan, S., and Katare, O. P. (2016) Conjugation of docetaxel with multiwalled carbon nanotubes and codelivery with piperine: Implications on pharmacokinetic profile and anticancer activity Mol. Pharmaceutics 13, 2423-32 10.1021/acs.molpharmaceut.6b00183
31. Raza, K., Singh, B., Singla, S., Wadhwa, S., Garg, B., Chhibber, S., and Katare, O. P. (2013) Nanocolloidal carriers of isotretinoin: antimicrobial activity against Propionibacterium acnes and dermatokinetic modeling Mol. Pharmaceutics 10, 1958-1963 10.1021/mp300722f
32. Kumar, P., Sharma, G., Kumar, R., Singh, B., Malik, R., Katare, O. P., and Raza, K. (2016) Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences Int. J. Pharm. 515, 307-314 10.1016/j.ijpharm.2016.10.024
33. Raza, K., Kumar, N., Misra, C., Kaushik, L., Guru, S. K., Kumar, P., Malik, R., Bhushan, S., and Katare, O. P. (2016) Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile Int. J. Biol. Macromol. 88, 206-212 10.1016/j.ijbiomac.2016.03.064
34. Gennari, O., Montesano, D., Salzano, A., Albrizio, S., and Grumetto, L. (2011) Determination of dimethyl fumarate in desiccant and antimould sachets by reversed-phase liquid chromatography Biomed. Chromatogr. 25, 1315-1318 10.1002/bmc.1602